Mirati Therapeutics, Inc. Gross Margin 2013-2023 | MRTX
Current and historical gross margin for Mirati Therapeutics, Inc. (MRTX) over the last 10 years. The current gross profit margin for Mirati Therapeutics, Inc. as of September 30, 2023 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-09-30 | $0.04B | $0.03B | 89.47% |
| 2023-06-30 | $0.03B | $0.02B | 88.89% |
| 2023-03-31 | $0.02B | $0.02B | 94.44% |
| 2022-12-31 | $0.01B | $0.01B | 100.00% |
| 2022-09-30 | $0.01B | $0.01B | 100.00% |
| 2022-06-30 | $0.08B | $0.08B | 100.00% |
| 2021-09-30 | $0.07B | $0.07B | 100.00% |
| 2020-12-31 | $0.01B | $0.01B | 100.00% |
| 2020-09-30 | $0.01B | $0.01B | 100.00% |
| 2020-03-31 | $0.00B | $0.00B | 100.00% |
| 2019-12-31 | $0.00B | $0.00B | 100.00% |
| 2019-09-30 | $0.01B | $0.01B | 100.00% |
| 2018-12-31 | $0.01B | $0.01B | 100.00% |
